Physician profile
Andrew W Simpson
NPI 1760400055
$5,177.59
in general payments reported to CMS, 2019-2025
18 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $126 · 2021: $2,581 · 2022: $173 · 2023: $64.50 · 2024: $913 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,264 · Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,263.73 |
| Food and Beverage | $897.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tricoast Surgical Solutions LLC | $1,492.94 | 2024-2025 | |
| Southtech Orthopedics | $1,451.40 | 2021 | |
| Arthrex, INC. | $778.33 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $753.68 | 2019-2022 | |
| Medtronic, INC. | $200.25 | 2021 | |
| Bioventus LLC | $120.03 | 2020-2025 | Durolane, Durolane |
| Smith+Nephew, INC. | $75.97 | 2020 | |
| Medacta USA, INC. | $51.00 | 2025 | Gmk Sphere |
| Vertex Pharmaceuticals Incorporated | $50.43 | 2025 | |
| Stryker Corporation | $48.30 | 2023-2024 | 1788 |
| Depuy Synthes Sales INC. | $35.04 | 2019-2025 | Monovisc, Orthovisc |
| Fortis Surgical, LLC | $21.36 | 2025 | |
| Ferring Pharmaceuticals INC. | $19.26 | 2024 | Euflexxa |
| Ermi LLC | $17.63 | 2024 | |
| Pacira Therapeutics, INC. | $17.54 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $17.46 | 2021 | |
| Avanos Medical | $14.53 | 2023 | Trivisc Sodium Hyaluronate |
| Janssen Pharmaceuticals, INC | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.